Switzerland

Gilead Sciences Switzerland Sàrl

General-Guisan-Strasse 8
6300 Zug
Switzerland

Phone: 41 (0)41 580 02 00 41 (0)41 580 02 00

Fax: 41 (0)41 580 02 98

Gilead Sciences is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

Gilead’s office in Zug is responsible for medical, sales and marketing activities for our products in Switzerland.

Read more about Transparency Reporting

Relationships with Patient Organizations and NGOs

ilead provided support to the following patient organizations and NGOs in 2021. The information is correct at the time of writing (May 2022). The information is subject to change and periodic updates. For a listing of previous years’ payments, click here.

Gilead Sciences EFPIA Patient Organisations Support 2021 - Switzerland

Publication of Clinical Study Results 

As of 2020, Gilead discloses clinical study results of newly authorized products in Switzerland by Swissmedic according to the requirements laid out in Art. 71-73 TPO (Ordinance on Therapeutic Products).

Products are listed in alphabetical order.

Product 

Active Substance

Authorization Number

Date of Authorization

Tecartus®

Autologous anti-CD19-transduced
CD3+ cells

67884

25.08.2021

Trodelvy®

Sacituzumab govitecan

68179

09.09.2021

Veklury®

Remdesivir

68026 / 68043

25.11.2020
24.05.2022

This page is intended for visitors outside of the United States.